Published 05:11 IST, October 15th 2020
UN stresses on WHO clearance for COVID-19 vaccines, Russia's Sputnik V included
UN spokesperson Stephane Dujarric said on Wednesday that any vaccine for the COVID-19 infection must be cleared by the World Health Organisation.
Advertisement
dressing a press conference on Wednesday, October 14 United Nations spokesperson Stephane Dujarric said that any vaccine for COVID-19 infection must be cleared by World Health Organisation. Earlier in September, Russian President Vlimir Putin in his speech at UN General Assembly h said that he will provide free Sputnik V vaccines to all UN staff worldwide.
Advertisement
"Those discussions are ongoing." "For us, it's important that any vaccine be cleared by WHO, but discussions are ongoing", said Stephane Dujarric.
In August, Russia h anunced that it h developed world's first registered vaccine named Sputnik V. vaccine registration raised concerns among Western scientists as COVID-19 vaccine developed by Moscow's Gamaleya research centre h received approval before clinical trials h been completed.
Advertisement
First registered COVID-19 vaccine
After anuncing world's first registered COVID-19 vaccine, Russia is reported to have begun early clinical trials for a second COVID-19 vaccine. According to vaccine developer, early clinical trials of a second Russian COVID-19 vaccine have proved successful.
Earlier on October 1, Vektor, Russia's state virology research centre in Siberia, said that early-st trials were successful for its own experimental vaccine, named 'EpiVacCorona'. first two phases of clinical trials demonstrated effectiveness and safety of EpiVacCorona vaccine, Vektor's press department told a Russian news ncy.
Advertisement
post-registration clinical trials would begin with 5,000 volunteers in Siberia, Vektor said and ded that re would be a separate clinical trial involving 150 volunteers who are over 60 years of . Furr, lab will begin placebo-controlled trials on 5,000 Russian volunteers between s of 18 and 60. Russia plans to manufacture an initial 10,000 doses and production is expected to begin in vember, Vektor informed.
Advertisement
(With ANI Inputs)
Advertisement
05:11 IST, October 15th 2020